Cited by 339Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains

Open access

Franz, Renate, Kelly, Steven L., Lamb, David C., Kelly, Diane E., Ruhnke, Markus, Morschhäuser, Joachim·1998·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.42.12.3065PMC PMC106000

Open this paper in CoChat — free account Open PDF

Abstract

From each of two AIDS patients with oropharyngeal candidiasis, five Candida albicans isolates from recurrent episodes of infection which became gradually resistant against fluconazole during antimycotic treatment were analyzed for molecular changes responsible for drug resistance. In both patients, a single C. albicans strain was responsible for the recurrent infections, but the CARE-2 fingerprint pattern of the isolates exhibited minor genetic alterations, indicating that microevolution of the strains took place during fluconazole therapy. In the isolates from patient 1, enhanced mRNA levels of the MDR1 gene, encoding a multiple drug resistance protein from the superfamily of major facilitators, and constitutive high expression of the ERG11 gene, coding for the drug target enzyme sterol 14alpha-demethylase, correlated with a stepwise development of fluconazole resistance. The resistant strains exhibited reduced accumulation of fluconazole and, for the last in the series, a slight increase in drug needed to inhibit sterol 14alpha-demethylation in vitro. In the isolates from patient 2, increased MDR1 mRNA levels and the change from heterozygosity to homozygosity for a mutant form of the ERG11 gene correlated with continuously decreased drug susceptibility. In this series, reduced drug accumulation and increased resistance in the target enzyme activity, sterol 14alpha-demethylase, were observed. These results demonstrate that different molecular mechanisms contribute to a gradual development of fluconazole resistance in C. albicans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/aac.42.12.3065

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,695
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 880
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents
Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
Sanglard, D., Ischer, F., Monod, M., & Billé, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2300 · Cited by 402
Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351
Self-citation

Flagged first, then by citations

Show all 38 references

Research works printed but not linked: 2

Ausubel F. M. Brent R. Kingston R. E. Moore D. D. Seidman J. G. Smith J. A. Struhl K. Current protocols in molecular biology. 1989 John Wiley & Sons Inc. New York N.Y
Odds F. C. Candida and candidosis: a review and bibliography. 1988 Bailliere Tindall London United Kingdom

Sorted by citations

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Fluconazole resistance in Candida species: a current perspective
Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 531
Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans
Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030164 · Cited by 355
Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents
Santos, G. C. D. O., Vasconcelos, C. C., Lopes, A. J. O., Cartágenes, M. D. S. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 380
Cinnamaldehyde and its derivatives, a novel class of antifungal agents
Shreaz, S., Wani, W. A., Behbehani, J. M., Raja, V., Irshad, M., Karched, M., Ali, I., Siddiqi, W. A., & Hun, L. T. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.05.016 · Cited by 355
An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1
Selmecki, A., Gerami‐Nejad, M., Paulson, C., Forche, A., & Berman, J. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06176.x · Cited by 325
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
Pfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314
Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates
Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., & Sanglard, D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00151-07 · Cited by 305
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285
Mutations in the multi‐drug resistance regulator MRR1 , followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strains
Dunkel, N., Blaß, J., Rogers, P. D., & Morschhäuser, J. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06309.x · Cited by 278
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
Morio, F., Loge, C., Besse, B., Hennequin, C., & Le Pape, P. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.11.006 · Cited by 279
Stress Alters Rates and Types of Loss of Heterozygosity in Candida albicans
Forche, A., Abbey, D., Pisithkul, T., Weinzierl, M. A., Ringstrom, T., Bruck, D., Petersen, K., & Berman, J. (2011) · mBio · doi:10.1128/mbio.00129-11 · Cited by 234
Fungal infections in animals: a patchwork of different situations
Seyedmousavi, S., Bosco, S. D. M. G., de Hoog, S., Ebel, F., Elad, D., Gomes, R. R., Jacobsen, I. D., Jensen, H. E., Martel, A., Mignon, B. R., et al. (2017) · Medical Mycology · doi:10.1093/mmy/myx104 · Cited by 277
Tandem Repeat of a Transcriptional Enhancer Upstream of the Sterol 14α-Demethylase Gene ( CYP51 ) in Penicillium digitatum
Hamamoto, H., Hasegawa, K., Nakaune, R., Lee, Y. J., Makizumi, Y., AKUTSU, K., & Hibi, T. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.8.3421-3426.2000 · Cited by 242
The genetic basis of fluconazole resistance development in Candida albicans
Morschhäuser, J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00087-x · Cited by 239
A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate
Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhäuser, J., & Rogers, P. D. (2008) · Eukaryotic Cell · doi:10.1128/ec.00103-08 · Cited by 236
Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?
Kelly, S. L., & Kelly, D. E. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0476 · Cited by 232
Self-citation
Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal
Costa-de-Oliveira, S., & Rodrigues, A. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020154 · Cited by 229
Upregulation of ERG Genes in Candida Species by Azoles and Other Sterol Biosynthesis Inhibitors
Henry, K. W., Nickels, J. T., & Edlind, T. D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2693-2700.2000 · Cited by 216
The 14α-Demethylasse(CYP51A1) Gene is Overexpressed in Venturia inaequalis Strains Resistant to Myclobutanil
Schnabel, G., & Jones, A. L. (2001) · Phytopathology · doi:10.1094/phyto.2001.91.1.102 · Cited by 214
Impact of fungal drug transporters on fungicide sensitivity, multidrug resistance and virulence
Waard, M. A. D., Andrade, A. C., Hayashi, K., Schoonbeek, H., Stergiopoulos, I., & Zwiers, L. H. (2006) · Pest Management Science · doi:10.1002/ps.1150 · Cited by 216
Resistance to antifungals that target CYP51
Parker, J. E., Warrilow, A. G. S., Price, C. L., Mullins, J. G. L., Kelly, D. E., & Kelly, S. L. (2014) · Journal of Chemical Biology · doi:10.1007/s12154-014-0121-1 · Cited by 217
Self-citation
Usefulness of Multilocus Sequence Typing for Characterization of Clinical Isolates of Candida albicans
Bougnoux, M., Morand, S., & d'Enfert, C. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1290-1297.2002 · Cited by 216
Tetracycline-Inducible Gene Expression and Gene Deletion in Candida albicans
Park, Y.-N., & Morschhäuser, J. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.8.1328-1342.2005 · Cited by 194
A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2 , two genes involved in antifungal drug resistance
de Micheli, M., Billé, J., Schueller, C., & Sanglard, D. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02814.x · Cited by 182
Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Rolley, N., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00348-10 · Cited by 168
Self-citation
Antifungal drug resistance of oral fungi
Niimi, M., Firth, N. A., & Cannon, R. D. (2010) · Odontology · doi:10.1007/s10266-009-0118-3 · Cited by 170
A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-10 · Cited by 165
Self-citation
Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans
Mukhopadhyay, K., Prasad, T., Saini, P., Pucadyil, T. J., Chattopadhyay, A., & Prasad, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1778-1787.2004 · Cited by 163
Targeted gene disruption in Candida albicans wild‐type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates
Wirsching, S., Michel, S., & Morschhäuser, J. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01899.x · Cited by 158
Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates
Rogers, P. D., & Barker, K. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1220-1227.2003 · Cited by 158
Evolution of Drug Resistance in Candida Albicans
Cowen, L. E., Anderson, J. B., & Kohn, L. M. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160907 · Cited by 151
Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans
Sharma, M., Manoharlal, R., Puri, N., & Prasad, R. (2009) · Bioscience Reports · doi:10.1042/bsr20090151 · Cited by 151
Plasma membrane lipids and their role in fungal virulence
Rella, A., Farnoud, A. M., & Poeta, M. D. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.11.003 · Cited by 150
Sequential gene disruption in Candida albicans by FLP‐mediated site‐specific recombination
Morschhäuser, J., Michel, S., & Staib, P. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01393.x · Cited by 147
A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise
Howard, K. C., Dennis, E. K., Watt, D. S., & Garneau‐Tsodikova, S. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00556k · Cited by 149
Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750
Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., & Scalise, G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1578-1584.2000 · Cited by 145
Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter‐encoding gene, CnAFR1, involved in the resistance to fluconazole
Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., Morace, G., & Fadda, G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03281.x · Cited by 143
An A643T Mutation in the Transcription Factor Upc2p Causes Constitutive ERG11 Upregulation and Increased Fluconazole Resistance in Candida albicans
Heilmann, C. J., Schneider, S., Barker, K. S., Rogers, P. D., & Morschhäuser, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01102-09 · Cited by 142
Specific Chromosome Alterations in Fluconazole-Resistant Mutants of Candida albicans
Perepnikhatka, V. I., Fischer, F. J., Niimi, M., Baker, R. A., Cannon, R. D., Wang, Y.-K., Sherman, F., & Rustchenko, E. P. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.13.4041-4049.1999 · Cited by 141
Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification
Wolfger, H., Mamnun, Y. M., & Kuchler, K. (2001) · Research in Microbiology · doi:10.1016/s0923-2508(01)01209-8 · Cited by 138
In Vitro Low-Level Resistance to Azoles in Candida albicans Is Associated with Changes in Membrane Lipid Fluidity and Asymmetry
Kohli, A., Smriti, N., Mukhopadhyay, K., Rattan, A., & Prasad, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1046-1052.2002 · Cited by 137
Activity of phenolic compounds from plant origin against Candida species
Martins, N. A., Barros, L., Henriques, M., Silva, S. M., & Ferreira, I. C. F. R. (2015) · Industrial Crops and Products · doi:10.1016/j.indcrop.2015.05.067 · Cited by 138
Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?
Gois, P. H. F., Ferreira, D., Olenski, S., & Seguro, A. C. (2017) · Nutrients · doi:10.3390/nu9070651 · Cited by 141
Fluconazole resistance in Candida albicans: a review of mechanisms.
Casalinuovo, I. A., Francesco, P. D., & Garaci, E. (2004) · PubMed · Cited by 132
Molecular Mechanisms of Drug Resistance in Clinical Candida Species Isolated from Tunisian Hospitals
Eddouzi, J., Parker, J. E., Vale-Silva, L. A., Coste, A., Ischer, F., Kelly, S., Manai, M., & Sanglard, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00555-13 · Cited by 128
Self-citation
Molecular aspects of fluconazole resistance development in Candida albicans
Franz, R., Ruhnke, M., & Morschhäuser, J. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00498.x · Cited by 129
Self-citation
Plagiochin E, an antifungal active macrocyclic bis(bibenzyl), induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway
Wu, X., Chang, W., Cheng, A., Sun, L., & Lou, H. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.01.001 · Cited by 129
Regulation of pleiotropic drug resistance in yeast
Kołaczkowska, A., & Goffeau, A. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0113 · Cited by 123
Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon
Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhäuser, J., Nantel, A., Raymond, M., & Rogers, P. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00327-07 · Cited by 123
Clonal and Spontaneous Origins of Fluconazole Resistance in Candida albicans
Xu, J., Ramos, A. R., Vilgalys, R., & Mitchell, T. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1214-1220.2000 · Cited by 123
Antifungals and Drug Resistance
Hossain, C. M., Ryan, L. K., Gera, M., Choudhuri, S., Lyle, N., Ali, K. A., & Diamond, G. (2022) · Encyclopedia · doi:10.3390/encyclopedia2040118 · Cited by 135
Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil
Goldman, G. H., Ferreira, M. E. D. S., Marques, E. D. R., Savoldi, M., Perlin, D. S., Park, S., Godoy-Martinez, P. C., Goldman, M. H. S., & Colombo, A. L. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.04.009 · Cited by 119
The development of fluconazole resistance in Candida albicans – an example of microevolution of a fungal pathogen
Morschhäuser, J. (2016) · Journal of Microbiology · doi:10.1007/s12275-016-5628-4 · Cited by 118
Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans
Barker, K. S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh336 · Cited by 117
The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity
Kelly, S. L., Lamb, D. C., Loeffler, J., Einsele, H., & Kelly, D. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1136 · Cited by 116
Self-citation
The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans
Sharma, M., & Prasad, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00344-11 · Cited by 116
Azole Binding Properties of Candida albicans Sterol 14-α Demethylase (CaCYP51)
Warrilow, A. G. S., Martel, C. M., Parker, J. E., Melo, N., Lamb, D. C., Nes, W. D., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00587-10 · Cited by 112
Self-citation
Targeted Short-Term Fluconazole Prophylaxis Among Very Low Birth Weight and Extremely Low Birth Weight Infants
Uko, S. E., Soghier, L. M., Vega, M., Marsh, J., Reinersman, G. T., Herring, L., Dave, V. A., Nafday, S. M., & Brion, L. P. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1969 · Cited by 110
Mitochondria Influence CDR1 Efflux Pump Activity, Hog1-Mediated Oxidative Stress Pathway, Iron Homeostasis, and Ergosterol Levels in Candida albicans
Thomas, E., Roman, E., Claypool, S., Manzoor, N., Pla, J., & Panwar, S. L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00889-13 · Cited by 105
Drug resistance genes and trailing growth in Candida albicans isolates
Lee, M.-K. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh040 · Cited by 105
Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450
Asai, K., Tsuchimori, N., Okonogi, K., Perfect, J. R., Gotoh, O., & Yoshida, Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1163 · Cited by 102
Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Molecular Mechanisms of Action of Herbal Antifungal Alkaloid Berberine, in Candida albicans
Dhamgaye, S., Devaux, F., Vandeputte, P., Khandelwal, N., Sanglard, D., Mukhopadhyay, G., & Prasad, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104554 · Cited by 101
Homozygosity at the Candida albicans MTL locus associated with azole resistance
Rustad, T. R., Stevens, D. A., Pfaller, M. A., & White, T. C. (2002) · Microbiology · doi:10.1099/00221287-148-4-1061 · Cited by 100
Resistance to Antifungal Drugs
Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 107
The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans
Znaidi, S., Deken, X. D., Weber, S., Rigby, T., Nantel, A., & Raymond, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05931.x · Cited by 97
Molecular aspects of azole antifungal action and resistance
Lamb, D. C., Kelly, D. E., & Kelly, S. L. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0112 · Cited by 97
Self-citation
Multiple Resistant Phenotypes of Candida albicans Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients
Lopez-Ribot, J. L., McAtee, R. K., Perea, S. H., Kirkpatrick, W. R., Rinaldi, M. G., & Patterson, T. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1621 · Cited by 94
Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis
Rogers, P. D., & Barker, K. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3412-3417.2002 · Cited by 96
The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans
Sasse, C., Dunkel, N., Schäfer, T., Schneider, S., Dierolf, F., Ohlsen, K., & Morschhäuser, J. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08210.x · Cited by 93
MDR1 -Mediated Drug Resistance in Candida dubliniensis
Wirsching, S., Moran, G. P., Sullivan, D. J., Coleman, D. C., & Morschhäuser, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3416-3421.2001 · Cited by 91
Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans
Hiller, D., Sanglard, D., & Morschhäuser, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1365-1371.2006 · Cited by 90
Evolution of microbial pathogens
Morschhäuser, J., Köhler, G. A., Ziebuhr, W., Blum–Oehler, G., Dobrindt, U., & Hacker, J. H. (2000) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0609 · Cited by 89
Activation of the Multiple Drug Resistance Gene MDR1 in Fluconazole-Resistant, Clinical Candida albicans Strains Is Caused by Mutations in a trans -Regulatory Factor
Wirsching, S., Michel, S., Köhler, G., & Morschhäuser, J. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.2.400-404.2000 · Cited by 88
Secretion of Natural and Synthetic Toxic Compounds from Filamentous Fungi by Membrane Transporters of the ATP-binding Cassette and Major Facilitator Superfamily
Stergiopoulos, I., Zwiers, L. H., & Waard, M. A. D. (2002) · European Journal of Plant Pathology · doi:10.1023/a:1020604716500 · Cited by 87
Secretion of natural and synthetic toxic compounds from filamentous fungi by membrane transporters of the ATP-binding cassette and major facilitator superfamily
Stergiopoulos, I., Zwiers, L. H., & Waard, M. A. D. (2002) · Springer eBooks · doi:10.1007/978-94-010-0001-7_16 · Cited by 84
Functional Analysis of Ca IPT1 , a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans
Prasad, T., Saini, P., Gaur, N. A., Vishwakarma, R. A., Khan, L. A., Haq, Q. M. R., & Prasad, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3442-3452.2005 · Cited by 83
Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis
Cernicka, J., & Šubík, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.12.005 · Cited by 83
Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors
Jain, P., Akula, I., & Edlind, T. D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3195-3201.2003 · Cited by 82
Candida albicans targets that potentially synergize with fluconazole
Lu, H., Shrivastava, M., Whiteway, M., & Jiang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1884641 · Cited by 81
Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism
Singh, S., Fatima, Z., Ahmad, K., & Hameed, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203079 · Cited by 82
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms
Sanglard, D., & Coste, A. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02157-15 · Cited by 82
Genes, Pathways, and Mechanisms Involved in the Virulence of Mucorales
Lax, C., Arques, C. P., Navarro-Mendoza, M. I., Cánovas-Márquez, J. T., Tahiri, G., Pérez-Ruiz, J. A., Osorio-Concepción, M., Murcia, L., Navarro, E., Garre, V., et al. (2020) · Genes · doi:10.3390/genes11030317 · Cited by 76
Impact of Antimicrobial Dosing Regimen on Evolution of Drug Resistance In Vivo: Fluconazole andCandida albicans
Andes, D. R., Forrest, A., Lepak, A. J., Nett, J. E., Marchillo, K., & Lincoln, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01053-05 · Cited by 76
Multiple mechanisms account for variation in base‐line sensitivity to azole fungicides in field isolates of Mycosphaerella graminicola
Stergiopoulos, I., van Nistelrooy, J. G. M., Kema, G. H. J., & Waard, M. A. D. (2003) · Pest Management Science · doi:10.1002/ps.766 · Cited by 72
Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance
Rognon, B., Kozovska, Z., Coste, A. T., Pardini, G., & Sanglard, D. (2006) · Microbiology · doi:10.1099/mic.0.29277-0 · Cited by 71
PDR16‐mediated azole resistance in Candida albicans
Saidane, S., Weber, S., Deken, X. D., St‐Germain, G., & Raymond, M. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05196.x · Cited by 72
Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p
Tong, Y., Zhang, J., Sun, N., Wang, X.-M., Wei, Q., Zhang, Y., Huang, R., Pu, Y., Dai, H., Ren, B., et al. (2021) · Science Bulletin · doi:10.1016/j.scib.2020.12.035 · Cited by 70
Curcumin acts synergistically with fluconazole to sensitize a clinical isolate of Candida albicans showing a MDR phenotype
Garcia-Gomes, A. D. S., Curvelo, J. A. D. R., Soares, R. M. A., & Ferreira‐Pereira, A. (2011) · Medical Mycology · doi:10.3109/13693786.2011.578156 · Cited by 69
Molecular Mechanism of Terbinafine Resistance in Saccharomycescerevisiae
Leber, R., Fuchsbichler, S., Klobučnı́ková, V., Schweighofer, N., Pitters, E., Wohlfarter, K., Lederer, M., Landl, K., Ruckenstuhl, C., Hapala, I., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3890-3900.2003 · Cited by 65
The Candida albicans Lanosterol 14-α-Demethylase ( ERG11 ) Gene Promoter Is Maximally Induced after Prolonged Growth with Antifungal Drugs
Song, J. L., Harry, J. B., Eastman, R. T., Oliver, B. G. G., & White, T. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1136-1144.2004 · Cited by 68
Understanding the mechanisms of resistance to azole antifungals in Candida species
Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 70
Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis
Pinjon, E., Moran, G. P., Jackson, C. J., Kelly, S. L., Sanglard, D., Coleman, D. C., & Sullivan, D. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2424-2437.2003 · Cited by 63
Self-citation
In search of the holy grail of antifungal therapy.
Chapman, S. W., Sullivan, D. C., & Cleary, J. D. (2008) · PubMed Central · Cited by 64

Authors: Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J.
Affiliations: University of Würzburg (DE)
Aberystwyth University (GB)
Humboldt-Universität zu Berlin (DE)
Zentrum für Infektionsforschung, Universität Würzburg, D-97070 Würzburg,1 and
ORCID: Kelly, Steven L.
Lamb, David C.
Kelly, Diane E.
Ruhnke, Markus
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 1998-12
Volume: 42
Issue: 12
Pages: 3065-3072
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.42.12.3065
PMC: PMC106000
OpenAlex: W2160765565
Cited by: 339
References: 38
Citations by year: 2026: 6 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 4 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 8 · 2017: 14 · 2016: 11 · 2015: 10 · 2014: 16 · 2013: 12 · 2012: 7
FWCI: 9.08
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
PubMed Central (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
Funders: Bundesministerium für Bildung und Forschung
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: Candida albicans, fluconazole resistance, oropharyngeal candidiasis, AIDS, MDR1 gene, ERG11, sterol 14α-demethylase, major facilitator superfamily, drug accumulation, microevolution, recurrent infections, antifungal resistance mechanisms
MeSH terms: Alleles, Antifungal Agents, Candida albicans, Candidiasis, Cytochrome P-450 Enzyme System, Drug Resistance, Microbial, Gene Expression Regulation, Humans, Gas Chromatography-Mass Spectrometry, Microbial Sensitivity Tests, Nucleic Acid Hybridization, Oxidoreductases, RNA, Bacterial, Blotting, Southern, Blotting, Northern, Fluconazole, AIDS-Related Opportunistic Infections, Genes, MDR, Sterol 14-Demethylase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks